Beneficial Effect of Indapamide in Experimental Myocardial Ischemia
- 1 January 1992
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 5 (1) , 22-25
- https://doi.org/10.1093/ajh/5.1.22
Abstract
Indapamide, a nonthiazide chlorosulfamoyl diuretic, which possesses well-known antihypertensive properties, is able to scavenge free radical intermediates involved in lipid peroxidation. In this respect, it has almost the same level of action as a-tocopherol. Using an isolated working rat heart preparation, we investigated the effect of indapamide on the myocardial resistance to global total normothermic ischemia followed by reperfusion. The heart, isolated at the end of chronic oral pre-treatment (7 day at 3 mg/kg body weight/day), was submitted to ischemia for 15 min and then reper-fused. The main results were as follows: in the in-dapamide-treated group, 1) postischemic recovery of cardiac function was significantly better as compared to the untreated control group; 2) lactate de-hydrogenase (LDH) release measured after 15 min of reperfusion was significantly reduced; 3) the myocardial content of organic hydroperoxides (HPO), taken as an index of lipid peroxidation, was significantly lowered, whereas the activity of su-peroxide dismutase (SOD) and glutathione peroxi-dase (GPx) remained unchanged; and 4) electron spin resonance (ESR) analysis of coronary effluents, collected during the first minutes of reperfusion in the presence of the spin-trap 5,5-dimethyl-l-pyrro-line N-oxide (DMPO), revealed a significant modification in the treated group. These findings suggest that indapamide treatment is able to afford some protective effect to cardiac tissue during the early stage of postischemic reperfusion, and that this effect might be related to the antioxidant properties of indapamide. Am J Hypertens 1992;5:22-25Keywords
This publication has 0 references indexed in Scilit: